DMPI Stock UPDATES Delmar Pharma (DMPI) 0.6940 08/30/2014 13

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Delmar Pharma (DMPI) 0.6940 $DMPI

DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments
PR Newswire - Fri Aug 29, 7:00AM CDT
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company" today announced the filing of June 30, 2014 fiscal year-end financial statements. The Company recently changed its fiscal year end to June 30th in order to facilitate an application to list its common stock on a national securities exchange in the timeliest manner possible.

DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference
PR Newswire - Wed Aug 27, 1:57PM CDT
DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The presentation will take place Tuesday, September 9th at 2:55 p.m. EDT in the Kennedy II Salon (4th floor) at the New York Palace Hotel in New York City. The presentation can be viewed live via webcast at http://wsw.com/webcast/rrshq24/dmpi and will be available for 90 days following the conference.

DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer
PR Newswire - Tue Aug 19, 7:00AM CDT
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company" announced today a protocol amendment to allow for expanded dosing in its VAL-083 clinical trial had been filed with the U.S. Food and Drug Administration (FDA) and that a new cohort of a new 50mg/m2 has been opened at three clinical trial sites in the United States. The company also confirmed that gross proceeds of US$2.9 million have been raised through warrant exercise in two separate closings. These funds provide sufficient working capital to fund DelMar's current operations, including its glioblastoma clinical trial, through at least December 2015.

DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial
PR Newswire - Thu Jul 24, 3:07PM CDT
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company" announced today that the company's board of directors approved a change of the company's fiscal year from December 31 to June 30. Accordingly, DelMar will file a Transition Form 10K on or before September 30, 2014.

DelMar Pharmaceuticals secures up to CAD194,000 in NRC-IRAP funding
M2 - Thu Jul 10, 7:20AM CDT
Cancer therapies company DelMar Pharmaceuticals (OTC BB MPI) revealed on Wednesday the receipt of a non-refundable financial contribution of up to CAD194,000 from the National Research Council of Canada's Industrial Research Assistance Programme (NRC-IRAP).

DelMar Pharmaceuticals Receives Funding from the Canadian Federal Government
PR Newswire - Wed Jul 09, 7:00AM CDT
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" announced today that the company has been awarded a non-refundable financial contribution of up to CDN$194,000 from the National Research Council of Canada's Industrial Research Assistance Program (NRC-IRAP).

BTV Reports on Roche, Sorrento Therapeutics Takes on a Goliath, Plus Biotech Up-and-Comers
Marketwire - Thu Jun 26, 5:01AM CDT
BTV-Business Television goes on location to bring investors expert analyst commentary and stories on emerging companies for their portfolio.

SeeThruEquity Issues 1Q 2014 Update on DelMar Pharmaceuticals, Inc. Highlighting VAL-083 Updates and Exercise of Warrants
ACCESSWIRE - Tue Jun 17, 8:02AM CDT
New York, NY / ACCESSWIRE / June 17, 2014 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a 4Q 2013 update note on DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), a biotechnology company focused on proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments.

DelMar Pharmaceuticals Gives Quarterly Shareholder Update and Announces Investor Conference Call
PR Newswire - Thu Mar 20, 7:00AM CDT
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma" provided an update as of the quarter ended December 31, 2013 and a summary of progress toward the Company's goals for the year. DelMar also announced an investor conference call to take place today at 1 pm EDT. Details and log-in information will be posted on the website at www.delmarpharma.com in advance of the call.

SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc.'s VAL-083 Clinical Trial
PR Newswire - Thu Mar 06, 8:00AM CST
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), a biotechnology company focused on proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The note is focuses on DelMar Pharmaceuticals recent update on the company's ongoing Phase I/II clinical trial for VAL-083 in recurrent glioblastoma (GBM).

DelMar Pharmaceuticals to Present at the 26th Annual ROTH Capital Conference
PR Newswire - Tue Mar 04, 7:00AM CST
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma" a pharmaceutical company developing its VAL-083 chemotherapy as a potential new therapy for glioblastoma multiforme, today announced that Jeffrey A. Bacha, President and CEO of DelMar Pharmaceuticals, Inc., will present at the upcoming 26th Annual ROTH Capital Conference.

DelMar Pharmaceuticals Provides Update on VAL-083 Glioblastoma Clinical Trial
PR Newswire - Wed Feb 26, 7:00AM CST
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma" provided an update on the company's ongoing Phase I/II clinical trial for VAL-083 in recurrent glioblastoma (GBM).

Many Business Leaders Only Play The Game While Others Change The Game
PR Newswire - Tue Feb 11, 7:30AM CST
America's PremierExperts® recently showcased a group of the country's leading businesspeople from various industries who are not just "playing the game" but they are changing it.

SeeThruEquity Initiates Research Coverage on DelMar Pharmaceuticals, Inc.
PR Newswire - Mon Jan 13, 8:00AM CST
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), a biotechnology company focused on proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments.

DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV
PR Newswire Europe - Thu Sep 19, 7:01AM CDT
-- Glioblastoma is the most common form of brain cancer, and DelMar is developing VAL-083 in the U.S. and China to treat aggressive cancers

DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
PR Newswire - Mon Sep 16, 11:09AM CDT
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), developer of advanced cancer therapeutics, today announced that their September 12th RetailInvestorConferences.com presentation is now available for on-demand viewing. DelMar is developing VAL-083 in U.S. and China to treat aggressive cancers.

CCG Investor Relations Announces Company Presenters for NexGen Life Sciences Virtual Conference
PR Newswire - Wed Sep 11, 8:00AM CDT
CCG Investor Relations, a leading global investor relations and strategic communications consultancy, is pleased to announce the companies who will present their investment stories as part of the Life Sciences Virtual Investment Conference to be held on Thursday, September 12, 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PARRIS Partners Earn 2026 Plaintiff Lawyer Recognition

Updated Category News Views 95

A $58.4 million jury number can make a courtroom sound like a slot machine, until the final settlement lands at $21 million. That gap is the part people ought to stare at before getting carried away by another plaintiff-lawyer honor roll. The Daily Journal has named PARRIS Law Firm partners Alexander R. Wheeler and Khail A. Parris to its 2026 Top Plaintiff Lawyers special...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
Mining's Biodiversity Map Sharpens Location Risks

Updated Category News Views 208

Twelve thousand pins on a map do not settle the mining industry's nature problem, but they do make it much harder to pretend the problem is evenly spread. ICMM's new Global Mining and Metals Biodiversity Dataset overlays 12,000 large-scale formal mining, smelting, refining and processing facilities with ecosystem-condition and conservation indicators. For investors...

Continue Reading
SAGA's Radar Assays Tighten the Trapper North Case

Updated Category News Views 188

Rock that keeps showing up where the model says it should is the sort of boring news a junior miner desperately needs. SAGA Metals has put out fresh assay results from Radar’s Trapper North area, and the useful part is not merely a loud grade in one hole. It is the apparent persistence of thick titanium-vanadium-iron oxide mineralization across tighter-spaced drilling....

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 164

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Norfolk Southern's 200-Year Campaign Meets a Hard Market

Updated Category News Views 83

Two centuries of railroad history can stir the blood, but it does not move a single carload by itself. Norfolk Southern has opened its 200-year railroading celebration with the GeneratioNS campaign, a three-locomotive NS 200 commemorative series, and plans for public events across its network. For a railroad with deep roots and very modern operational pressures, this is...

Continue Reading
Whole-House Remodels Need a Plan Before Any Finishes

Updated Category News Views 47

A remodel gets expensive the minute somebody falls in love with tile before checking what sits behind the wall. Adam Sherman’s central point in the HelloNation article is refreshingly unglamorous: treat the house as one working system before treating it as a collection of rooms crying out for cosmetic rescue. That sounds obvious until you see how often a kitchen...

Continue Reading
Zoomlion’s Australian Service Push Looks Built to Last

Updated Category News Views 41

Five Australian business centres are one thing; getting a stalled crane or earthmover moving again is the whole ballgame. Zoomlion’s Nov. 4 customer gathering in Sydney matters because Chairman and CEO Zhan Chunxin kept the discussion on the unglamorous stuff: product quality, technical support, parts availability and local training. That is exactly where an equipment...

Continue Reading
Early Dog Guarding Signs Matter Before a Sudden Growl

Updated Category News Views 104

A bowl, a chewed-up toy, or a patch of couch can turn tense in a heartbeat. That is why the useful part of Brian Manning's guidance is not some fantasy of making every dog endlessly tolerant; it is learning to notice discomfort while there is still room to back off safely. For anybody watching the pet-care and behavior-training field, this is the kind of plainspoken...

Continue Reading
Katahdin's Portland Branch Bet Moves Downtown in 2027

Updated Category News Views 141

Exchange Street is getting a real-world vote of confidence, and that is more interesting than another app update ever will be. Katahdin Trust intends to open a full-service branch at 120 Exchange Street in downtown Portland, with renovations slated to begin early in 2027 and an opening expected later that year. For a Maine community bank with nearly $1.2 billion in...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Monport MEGA: Revolutionizing Laser Engraving

Updated Category News Views 100

Monport Launches the MEGA: A Game Changer in Laser Engraving Monport Laser is excited to unveil the MEGA, the revolutionary desktop CO2 laser engraving machine that is set to redefine the standards of efficiency and safety in the industry. This innovative machine embodies a blend of advanced technology and user-friendly design, ensuring that both professionals and...

Continue Reading
Key Insights on Recent Managerial Transactions at Digitalist

Updated Category News Views 107

Recent Managerial Transactions at Digitalist Group Digitalist Group Oy has seen significant managerial activities recently, particularly involving key board members. The transactions not only reflect the movements within the company but also provide insights into the internal management strategies being implemented. Understanding the Notification Requirement The...

Continue Reading
Gold Prices Hold Steady Amid Economic Signals and Tariff Talks

Updated Category News Views 147

Gold Prices Resilient Despite Mixed Economic Factors Gold prices have shown little movement in recent Asian trading sessions. Investors are closely watching potential trade tariffs proposed by the incoming U.S. administration, while a recent dip in the dollar is providing some support for the precious metal. Throughout December, bullion prices experienced some losses due...

Continue Reading
Transforming Bitcoin Mining: HAKA MINING's Innovative Solutions

Updated Category News Views 275

Harnessing the Future of Bitcoin Mining HAKA MINING is making waves in the cryptocurrency sector with its dedicated approach to cloud mining. This UK-based company is not only providing opportunities for passive income but is also championing sustainability in energy use. This innovative cloud mining service empowers users to accumulate cryptocurrency efficiently and...

Continue Reading
RWE Unveils Solar Project, Boosting Jobs and Local Economy

Updated Category News Views 248

RWE Hits Milestone with New Solar Farm Development RWE is celebrating a significant advancement as onsite construction begins for the 98 MWac Union Ridge Solar farm, demonstrating a robust commitment to renewable energy and job creation. This project is positioned to generate jobs and foster economic opportunities in the surrounding regions. Collaborative Efforts with...

Continue Reading